Progress toward a blood test for early pancreatic cancer
February 24, 2026 At a Glance Researchers identified markers in blood that could be used to identify people…
NALIRIFOX Expands Options in First-Line Metastatic Pancreatic Cancer
Following the February 2024 FDA approval of irinotecan liposome (Onivyde) with oxaliplatin, fluorouracil, and leucovorin (NALIRIFOX), patients with…